Open29.460 | Close- |
Vol / Avg.213.227K / 798.605K | Mkt Cap1.710B |
Day Range29.060 - 29.930 | 52 Wk Range18.611 - 61.940 |
Harmony Biosciences Stock (NASDAQ: HRMY) stock price, news, charts, stock research, profile.
Open29.460 | Close- |
Vol / Avg.213.227K / 798.605K | Mkt Cap1.710B |
Day Range29.060 - 29.930 | 52 Wk Range18.611 - 61.940 |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.650 | 0.970 | 0.3200 | ||||
REV | 148.870M | 160.268M | 11.398M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-01 | Needham | Ami Fadia | Reiterates | BuyBuy | Maintains | - | 53.00 |
2023-11-01 | Raymond James | Danielle Brill | Maintains | OutperformOutperform | Raises | 26.00 | 27.00 |
2023-10-16 | Piper Sandler | David Amsellem | Maintains | OverweightOverweight | Lowers | 72.00 | 42.00 |
2023-10-16 | Needham | Ami Fadia | Maintains | BuyBuy | Lowers | 66.00 | 53.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HRMY | Harmony Biosciences | 0% | 1.7B |
VRNA | Verona Pharma | 3.97% | 1.1B |
SUPN | Supernus Pharmaceuticals | 0% | 1.5B |
CBAY | CymaBay Therapeutics | 3.46% | 2.2B |
NMRA | Neumora Therapeutics | -1.07% | 1.8B |
You can purchase shares of Harmony Biosciences (NASDAQ: HRMY) through any online brokerage.
Other companies in Harmony Biosciences’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), CymaBay Therapeutics (NASDAQ:CBAY), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).
The latest price target for Harmony Biosciences (NASDAQ: HRMY) was reported by Needham on Wednesday, November 1, 2023. The analyst firm set a price target for 53.00 expecting HRMY to rise to within 12 months (a possible 80.27% upside). 34 analyst firms have reported ratings in the last year.
The stock price for Harmony Biosciences (NASDAQ: HRMY) is $29.4 last updated November 29, 2023 at 9:00 PM UTC.
There is no dividend information for Harmony Biosciences.
Harmony Biosciences’s Q4 earnings are confirmed for Tuesday, February 20, 2024.
There is no upcoming split for Harmony Biosciences.
Harmony Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.